Showing results (261-270 of 323) with videos related to
Sort By:
Pageof 33
European Journal of Cancer (Oxford, England : 1990)|April 10, 2024
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trialsAlessandra Raimondi, Young Woo Kim, Won Ki Kang, et al.The Oncologist|September 2, 2017
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyValentina Fanotto, Mario Uccello, Irene Pecora, et al.The Pharmacogenomics Journal|February 7, 2019
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patientsMarzia Del Re, Saverio Cinieri, Angela Michelucci, et al.European Journal of Cancer (Oxford, England : 1990)|December 15, 2020
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancerPaolo Manca, Salvatore Corallo, Giovanni Randon, et al.Journal of the National Cancer Institute|April 7, 2021
EGFR Amplification in Metastatic Colorectal CancerGiovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.The Lancet. Oncology|August 8, 2024
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trialKanwal Raghav, Salvatore Siena, Atsuo Takashima, et al.Journal of Hematology & Oncology|December 15, 2023
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2Sara Pusceddu, Francesca Corti, Natalie Prinzi, et al.JAMA Oncology|July 4, 2019
Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical TrialFilippo Pietrantonio, Federica Morano, Salvatore Corallo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2019
Class 1, 2, and 3 <i>BRAF</i>-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular CharacterizationMarta Schirripa, Paola Biason, Sara Lonardi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control StudyFilippo Pietrantonio, Giovanni Fucà, Federica Morano, et al.Pageof 33